CLDX - Celldex Therapeutics, Inc.
29.43
0.070 0.238%
Share volume: 672,383
Last Updated: 03-06-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$29.36
0.07
0.00%
Summary score
16%
Profitability
0%
Dept financing
5%
Liquidity
75%
Performance
20%
Sector
Manufacturing
Industry
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-15.03%
Return on assets
-9.09%
Return on sales
-2047.9%
Return on invested capital
-43.04%
Total debt ratio
24.47%
Debt ratio change over timeo
0%
Current Ratio
7.65%
Quick Ratio
16.63%
Cash Position Ratio
2.99%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-9.25%
Return on assets
-7.96%
Return on sales
-2047.9%
Return on invested capital
-28.15%
Total debt ratio
17%
Debt ratio change over timeo
0%
Current Ratio
11.69%
Quick Ratio
16.63%
Cash Position Ratio
6.42%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-6.19%
Return on assets
-5.35%
Return on sales
-2047.9%
Return on invested capital
-35%
Total debt ratio
10.09%
Debt ratio change over time
0%
Current Ratio
16.63%
Quick Ratio
16.63%
Cash Position Ratio
16.36%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CLDX | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | -15.03% | -440.43% | 31.03% | 4.64% |
| Return on assets | -9.09% | 7.49% | 3.24% | 4.35% |
| Return on sales | -2047.9% | 22.38% | 12.93% | 19.99% |
| Return on invested capital | -43.04% | 34.57% | 7.56% | 5.98% |
| Profitability | 0% | 75% | 56% | 45% |
| Total debt ratio | 24.47% | 97.16% | 90.34% | 47.07% |
| Debt ratio change over time | 0% | 0% | 10.66% | 0% |
| Dept financing | 6% | 25% | 48% | 12% |
| Current Ratio | 11.69% | 1.15% | 2.54% | 2.05% |
| Quick Ratio | 16.63% | 0.81% | 2.07% | 1.58% |
| Cash Position Ratio | 6.42% | 0.19% | 1.3% | 0.5% |
| Liquididy | 75% | 6% | 27% | 28% |
| Short-term ratios | CLDX | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | -9.25% | 60.65% | 2.33% | 12.63% |
| Return on assets | -7.96% | 7.96% | 0.9% | 10.75% |
| Return on sales | -2047.9% | 23.77% | 1.86% | 40.65% |
| Return on invested capital | -28.15% | 23.12% | 1.54% | 18.65% |
| Profitability | 0% | 83% | 6% | 75% |
| Total debt ratio | 17% | 87.29% | 56.37% | 36.76% |
| Debt ratio change over time | 0% | 0% | 4.57% | 0% |
| Dept financing | 5% | 25% | 41% | 11% |
| Current Ratio | 11.69% | 1.15% | 2.54% | 2.05% |
| Quick Ratio | 16.63% | 0.81% | 2.07% | 1.58% |
| Cash Position Ratio | 6.42% | 0.19% | 1.3% | 0.5% |
| Liquididy | 75% | 4% | 14% | 9% |